![Lekhram Changoer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lekhram Changoer
Direttore Tecnico/Scientifico/R&S presso CANAFARMA HEMP PRODUCTS CORP.
Patrimonio netto: 2 M $ in data 30/06/2024
Posizioni attive di Lekhram Changoer
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANAFARMA HEMP PRODUCTS CORP. | Direttore Tecnico/Scientifico/R&S | - | - |
INCANNEX HEALTHCARE INC. | Direttore Tecnico/Scientifico/R&S | 05/07/2023 | - |
Stichting Sanammad | Direttore/Membro del Consiglio | 01/01/2009 | - |
Corporate Officer/Principal | 01/01/2009 | - | |
Sanammad Pharmaceuticals BV | Direttore/Membro del Consiglio | 01/01/2014 | - |
Corporate Officer/Principal | 01/01/2014 | - |
Storia della carriera di Lekhram Changoer
Precedenti posizioni note di Lekhram Changoer
Società | Posizione | Inizio | Fine |
---|---|---|---|
AXIM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/05/2014 | 06/05/2020 |
Direttore Tecnico/Scientifico/R&S | 01/05/2014 | 06/05/2020 | |
APIRX Pharmaceuticals USA LLC
![]() APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Fondatore | - | - |
CanChew Biotechnologies LLC
![]() CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Direttore/Membro del Consiglio | 01/01/2012 | - |
Direttore Tecnico/Scientifico/R&S | 30/07/2013 | - | |
Fondatore | 01/01/2012 | - |
Statistiche
Distribuzione geografica
Paesi Bassi | 4 |
Stati Uniti | 3 |
Canada | 2 |
Posizioni
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Settori
Health Technology | 5 |
Miscellaneous | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
AXIM BIOTECHNOLOGIES, INC. | Health Technology |
CANAFARMA HEMP PRODUCTS CORP. | Process Industries |
INCANNEX HEALTHCARE INC. | Health Technology |
Aziende private | 4 |
---|---|
CanChew Biotechnologies LLC
![]() CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
Stichting Sanammad | Miscellaneous |
Sanammad Pharmaceuticals BV | |
APIRX Pharmaceuticals USA LLC
![]() APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Borsa valori
- Insiders
- Lekhram Changoer
- Esperienza